Palestine

Category: 4. Health

  • New genetic cause of neurodevelopmental disorders

    New genetic cause of neurodevelopmental disorders

    A seminal study from researchers at the Icahn School of Medicine at Mount Sinai and their collaborators in the United Kingdom, Belgium, Spain, the Netherlands, and Iceland has uncovered a new genetic cause of neurodevelopmental disorders (NDDs). The discovery offers both closure and hope to potentially thousands of families worldwide who have long been searching for answers.

    The study, published in the April 10online issue of Nature Genetics, reveals that mutations in a small, previously…

    Continue Reading


    News Source: www.sciencedaily.com

  • Impact of processing on biochemical composition of plant-based products revealed

    Impact of processing on biochemical composition of plant-based products revealed

    A study conducted at the Food Sciences unit of the University of Turku in Finland showed that different processing methods significantly affect the biochemical composition of plant-based foods. Current food classification systems do not sufficiently acknowledge the biochemical composition of the product.

    A plant-based diet is beneficial for health, and with population growth and environmental pressures, the proportion of plant products in the diet should be emphasised over animal products….

    Continue Reading


    News Source: www.sciencedaily.com

  • Study shows how new antibody therapy works against ovarian cancer

    Study shows how new antibody therapy works against ovarian cancer

    Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer.

    The research, from the group of Professor Sophia Karagiannis at King’s College London, could help to better understand the responses of patients who receive this type of therapy.

    Antibody treatments are a type of immunotherapy, which work by helping the body’s immune system to recognise and kill cancer cells. Almost all antibodies currently used in cancer treatment are…

    Continue Reading


    News Source: www.sciencedaily.com

  • ‘Eolving’ opioid epidemic across U.S.

    ‘Eolving’ opioid epidemic across U.S.

    The heart of the opioid epidemic that killed 665,341 people in the United States between 2005 and 2020 shifted geographically from the Northwest to the East, according to a new geographical analysis.

    In a study published in the journal The Lancet Regional Health — Americas, epidemiologists at the University of Cincinnati tracked the epicenter of this life-shattering epidemic over space and time across the country, driven largely by a move from prescription opiates to heroin to synthetic…

    Continue Reading


    News Source: www.sciencedaily.com

  • Dogs could help predict valley fever spread in humans

    Dogs could help predict valley fever spread in humans

    Valley fever, or coccidioidomycosis, is caused by a fungus that thrives in moist soils and becomes airborne during drought. Its spores are easily inhaled, leading to infection. Climate change is creating the perfect conditions for it in the Western United States, with increasing heavy rains followed by prolonged drought. A new study by University of California, Davis, researchers shows that dogs, who are also susceptible to the disease, can help us understand its spread.

    “Dogs are sentinels…

    Continue Reading


    News Source: www.sciencedaily.com

  • A shadowy market for weight-loss drugs has emerged online

    A shadowy market for weight-loss drugs has emerged online

    In late 2022, pharmacist Joseph Lambson got an unusual call from a poison control specialist.

    He said, “Hey Joe, I’m getting these weird calls about semaglutide.” According to the specialist’s calculations, people were giving themselves 10 times the correct dose. But that didn’t make sense. The drug is the key ingredient in the blockbuster diabetes and weight-loss medications Ozempic and Wegovy. Both come in prefilled injector pens, which typically take the guesswork…

    Continue Reading


    News Source: www.sciencenews.org

  • Memory manipulation is the stuff of sci-fi. Someday it could be real

    Memory manipulation is the stuff of sci-fi. Someday it could be real

    In the world of Harry Potter, one’s memory can be manipulated with the flick of a wand. Albus Dumbledore reels wispy memories out of his head and puts them in a Pensieve. If he later dunks his head in that magical basin, he can see his past experiences with lifelike clarity. Hermione Granger, meanwhile, uses the spell “Obliviate” to remove herself from her parents’ memories to protect them from the wizarding world.

    In real life, memories are not storable liquids or files…

    Continue Reading


    News Source: www.sciencenews.org

  • Fill-in-the-blank training primes AI to interpret health data from smartwatches and fitness trackers

    Fill-in-the-blank training primes AI to interpret health data from smartwatches and fitness trackers

    The human body constantly generates a variety of signals that can be measured from outside the body with wearable devices. These bio-signals – ranging from heart rate to sleep state and blood oxygen levels – can indicate whether someone is having mood swings or can be used to diagnose a variety of body or brain disorders.

    It can be relatively cheap to gather a lot of bio-signal data. Researchers can organize a study and ask participants to use a wearable device akin to a smartwatch…

    Continue Reading


    News Source: theconversation.com

  • FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy

    FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy

    Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient recruitment for the phase 1 trial will begin soon (NCT06913608). The phase 1 clinical trial will evaluate the safety and efficacy of CLBR001 + SWI019 in patients with…

    Continue Reading


    News Source: www.sciencedaily.com

  • Certain nasal bacteria may boost the risk for COVID-19 infection, study finds

    Certain nasal bacteria may boost the risk for COVID-19 infection, study finds

    A new study from researchers at the George Washington University has found that certain bacteria living in the nose may influence how likely someone is to get a COVID-19 infection. Published in EBioMedicine, the research reveals that certain types of nasal bacteria can affect the levels of key proteins the virus needs to enter human cells, offering new insight into why some people are more vulnerable to COVID-19 than others.

    “We’ve known that the virus SARS-CoV-2 enters the body through the…

    Continue Reading


    News Source: www.sciencedaily.com